FindTrial
Sign In

Salvage Therapy

PROCEDURE7 trials

Sponsors

The HIV Netherlands Australia Thailand Research Collaboration, H. Lee Moffitt Cancer Center and Research Institute, Tanta University, Harbin Hematology and Oncology Institute, Melanoma Institute Australia

Conditions

B-precursor Acute Lymphoblastic LeukemiaHIV InfectionsHepatitis CMelanoma Stage IvPeripheral T Cell LymphomaProstate CancerRecurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma

Phase 2

Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA
TerminatedNCT01531205
H. Lee Moffitt Cancer Center and Research InstituteProstate Cancer
Start: 2012-05-31End: 2013-10-31Updated: 2014-11-05
Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study)
RecruitingNCT03340129
Melanoma Institute AustraliaMelanoma Stage Iv
Start: 2019-08-14End: 2029-08-01Target: 218Updated: 2026-02-02
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma
Not yet recruitingNCT07572123
National Cancer Institute (NCI)Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma
Start: 2026-12-04End: 2029-03-31Target: 374Updated: 2026-05-13

Phase 4

Safety and Efficacy of Sofosbuvir-Based Regimens in the Treatment of Egyptian Patients With Hepatitis C Infection
CompletedNCT02992457
Tanta UniversityHepatitis C
Start: 2015-01-31End: 2019-12-31Updated: 2023-08-25

Unknown Phase

Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs
CompletedNCT00477308
The HIV Netherlands Australia Thailand Research CollaborationHIV Infections
Start: 2006-01-31End: 2009-04-30Updated: 2020-07-17
Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL
CompletedNCT03123887
Harbin Hematology and Oncology InstituteB-precursor Acute Lymphoblastic Leukemia
Start: 2015-07-10End: 2016-10-10Updated: 2017-04-21
T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR
RecruitingNCT07470996
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePeripheral T Cell Lymphoma
Start: 2025-10-01End: 2029-09-30Target: 58Updated: 2026-03-13

Related Papers

Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
Clinical and Translational Radiation Oncology2023-02-152 citations
Five-year overall survival from the anti-PD1 brain collaboration (ABC Study): Randomized phase 2 study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets).
Journal of Clinical Oncology2021-05-2098 citations
High success rates for the use of sofosbuvir/ombitasvir/paritaprevir/ritonavir + ribavirin and sofosbuvir/simeprevir/daclatasvir + ribavirin in retreatment of chronic hepatitis C infection after unsuccessful sofosbuvir/daclatasvir therapy: a real-life experience.
2020-04-305 citations
A phase II, open label, randomized controlled trial of nivolumab plus ipilimumab with stereotactic radiotherapy versus ipilimumab plus nivolumab alone in patients with melanoma brain metastases (ABC-X Trial).
Journal of Clinical Oncology2019-05-2024 citations
Efficacy and safety of sofosbuvir–ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
Infection and Drug Resistance2018-02-2840 citations